CVS Health posts Q2 net income of $2.98B, teams up with Lilly on weight-loss drugs
CVS CVS Health Corp
$87.01 +0.64%
View chart & analysis → - 1CVS Health (CVS) reported Q2 net income of $2.98 billion ($2.31 per share) and raised its full-year guidance significantly
- 2Adjusted EPS of $2.58 topped estimates of $1.85, while revenue rose about 7% to $106.1 billion
- 3In a partnership with Eli Lilly (LLY), CVS will display Zepbound and Foundayo pricing on its app and offer same-day pickup starting in early Q4 2026
Source The Wall Street Journal +9 · View original ↗
Today's 5 AI picks, all freeNothing hidden: past picks and how they did against the S&P 500.